Corcept Therapeutics Files 8-K
Ticker: CORT · Form: 8-K · Filed: Jul 14, 2025 · CIK: 1088856
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: CORT
TL;DR
Corcept Therapeutics filed an 8-K on 7/14/25. Details pending.
AI Summary
Corcept Therapeutics Inc. filed an 8-K on July 14, 2025, reporting on other events and financial statements/exhibits. The filing does not contain specific financial figures or details about the 'other events' within the provided text.
Why It Matters
This filing indicates a regulatory update from Corcept Therapeutics, which may contain important information for investors regarding company events or financial disclosures.
Risk Assessment
Risk Level: low — The filing is a standard 8-K without immediate negative or positive financial implications presented in the provided text.
Key Players & Entities
- Corcept Therapeutics Inc. (company) — Registrant
- July 14, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 101 Redwood Shores Parkway (address) — Principal Executive Offices
- Redwood City, CA 94065 (address) — Principal Executive Offices
FAQ
What specific 'Other Events' are being reported by Corcept Therapeutics in this 8-K filing?
The provided text for the 8-K filing lists 'Other Events' as an item information but does not specify the nature of these events.
What financial statements or exhibits are included with this 8-K filing?
The filing indicates 'Financial Statements and Exhibits' as item information, but the specific contents are not detailed in the provided text.
When was this 8-K filing submitted to the SEC?
The filing was submitted on July 14, 2025, as indicated by the 'FILED AS OF DATE' and 'DATE AS OF CHANGE'.
What is Corcept Therapeutics Inc.'s principal executive office address?
Corcept Therapeutics Inc.'s principal executive offices are located at 101 Redwood Shores Parkway, Redwood City, CA 94065.
What is the Commission File Number for Corcept Therapeutics Inc.?
The Commission File Number for Corcept Therapeutics Inc. is 000-50679.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 14, 2025 regarding CORCEPT THERAPEUTICS INC (CORT).